SG10202101108RA - Compositions that metabolize or sequester free sugar monomers and uses thereof - Google Patents
Compositions that metabolize or sequester free sugar monomers and uses thereofInfo
- Publication number
- SG10202101108RA SG10202101108RA SG10202101108RA SG10202101108RA SG10202101108RA SG 10202101108R A SG10202101108R A SG 10202101108RA SG 10202101108R A SG10202101108R A SG 10202101108RA SG 10202101108R A SG10202101108R A SG 10202101108RA SG 10202101108R A SG10202101108R A SG 10202101108RA
- Authority
- SG
- Singapore
- Prior art keywords
- metabolize
- compositions
- free sugar
- sugar monomers
- sequester free
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Pediatric Medicine (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562133239P | 2015-03-13 | 2015-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202101108RA true SG10202101108RA (en) | 2021-03-30 |
Family
ID=56919333
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202002010VA SG10202002010VA (en) | 2015-03-13 | 2016-03-11 | Compositions that metabolize or sequester free sugar monomers and uses thereof |
SG10202101108RA SG10202101108RA (en) | 2015-03-13 | 2016-03-11 | Compositions that metabolize or sequester free sugar monomers and uses thereof |
SG11201707506WA SG11201707506WA (en) | 2015-03-13 | 2016-03-11 | Compositions that metabolize or sequester free sugar monomers and uses thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202002010VA SG10202002010VA (en) | 2015-03-13 | 2016-03-11 | Compositions that metabolize or sequester free sugar monomers and uses thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707506WA SG11201707506WA (en) | 2015-03-13 | 2016-03-11 | Compositions that metabolize or sequester free sugar monomers and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (2) | US20180078589A1 (en) |
EP (1) | EP3268019A4 (en) |
CN (2) | CN116270760A (en) |
AU (2) | AU2016233529B2 (en) |
BR (1) | BR112017019468A2 (en) |
CA (1) | CA2979529A1 (en) |
MX (1) | MX2017011669A (en) |
SG (3) | SG10202002010VA (en) |
WO (1) | WO2016149149A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX338174B (en) | 2010-12-31 | 2016-04-06 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents. |
US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
CA2842672A1 (en) | 2011-07-22 | 2013-01-31 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
SG2014013478A (en) | 2011-08-29 | 2014-05-29 | Abbott Lab | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
HRP20191966T4 (en) | 2016-09-13 | 2022-09-16 | Allergan, Inc. | Stabilized non-protein clostridial toxin compositions |
CN106498087B (en) * | 2016-12-30 | 2020-01-07 | 广东环凯生物科技有限公司 | Clostridium perfringens dry pulverization LAMP (loop-mediated isothermal amplification) rapid detection kit and use method thereof |
EP3675882A4 (en) | 2017-08-30 | 2021-07-28 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
CN110327079A (en) * | 2019-06-28 | 2019-10-15 | 广州国盛基因信息科技有限公司 | A kind of intestinal flora detection system |
WO2023118510A1 (en) | 2021-12-22 | 2023-06-29 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716615A (en) * | 1992-02-10 | 1998-02-10 | Renata Maria Anna Cavaliere Vesely | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
RU2180915C1 (en) * | 2001-04-28 | 2002-03-27 | Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского | Consortium of bifidobacteria and lactobacilli used for preparing bacterial preparations, ferments for fermented-milk foodstuffs, fermented and nonfermented foodstuffs, biologically active supplements designated for correction of microflora in children in age below 3 years |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
US20110165127A1 (en) * | 2006-06-09 | 2011-07-07 | Fabiola Masri | Dairy-derived probiotic compositions and uses thereof |
WO2007140621A1 (en) * | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Probiotic compositions and uses thereof |
JP5074146B2 (en) * | 2007-03-30 | 2012-11-14 | オリンパス株式会社 | Capsule medical device |
UA32462U (en) * | 2008-02-14 | 2008-05-12 | Харьковский Национальный Медицинский Университет | Method for evaluation of effectiveness of correction of distortions of intestines microbiotsenosis in children of early age with atopic dermatitis |
US9649380B2 (en) * | 2009-01-12 | 2017-05-16 | Pfizer Italia S.R.L. | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
DK3209308T3 (en) * | 2014-10-24 | 2022-10-03 | Evolve Biosystems Inc | ACTIVATED BIFIDOBACTERIA AND METHODS OF USING THEREOF |
US10350249B2 (en) * | 2014-12-12 | 2019-07-16 | The Regents Of The University Of California | Reduction of milk glycans and their degradation products in the neonate gut |
-
2016
- 2016-03-11 CN CN202310095258.3A patent/CN116270760A/en active Pending
- 2016-03-11 BR BR112017019468A patent/BR112017019468A2/en not_active Application Discontinuation
- 2016-03-11 SG SG10202002010VA patent/SG10202002010VA/en unknown
- 2016-03-11 EP EP16765525.7A patent/EP3268019A4/en active Pending
- 2016-03-11 WO PCT/US2016/022226 patent/WO2016149149A1/en active Application Filing
- 2016-03-11 US US15/558,110 patent/US20180078589A1/en not_active Abandoned
- 2016-03-11 CN CN201680027417.4A patent/CN107847533A/en active Pending
- 2016-03-11 SG SG10202101108RA patent/SG10202101108RA/en unknown
- 2016-03-11 MX MX2017011669A patent/MX2017011669A/en unknown
- 2016-03-11 AU AU2016233529A patent/AU2016233529B2/en not_active Expired - Fee Related
- 2016-03-11 SG SG11201707506WA patent/SG11201707506WA/en unknown
- 2016-03-11 CA CA2979529A patent/CA2979529A1/en not_active Abandoned
-
2019
- 2019-11-06 US US16/676,163 patent/US20200237836A1/en not_active Abandoned
-
2022
- 2022-02-22 AU AU2022201172A patent/AU2022201172A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112017019468A2 (en) | 2018-05-15 |
CN107847533A (en) | 2018-03-27 |
EP3268019A1 (en) | 2018-01-17 |
AU2016233529A1 (en) | 2017-10-12 |
US20200237836A1 (en) | 2020-07-30 |
AU2022201172A1 (en) | 2022-03-17 |
CA2979529A1 (en) | 2016-09-22 |
CN116270760A (en) | 2023-06-23 |
AU2016233529B2 (en) | 2022-03-10 |
MX2017011669A (en) | 2017-11-06 |
EP3268019A4 (en) | 2018-10-31 |
WO2016149149A1 (en) | 2016-09-22 |
SG10202002010VA (en) | 2020-05-28 |
US20180078589A1 (en) | 2018-03-22 |
SG11201707506WA (en) | 2017-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258900A1 (en) | Delivery methods and compositions | |
HK1256225A1 (en) | Oligonucleotide compositions and methods thereof | |
HK1255370A1 (en) | Oligonucleotide compositions and methods thereof | |
HK1249028A1 (en) | Self-foaming compositions and methods | |
SG10202002010VA (en) | Compositions that metabolize or sequester free sugar monomers and uses thereof | |
GB2546350B (en) | Compositions and methods | |
EP3325620A4 (en) | Antiviral methods and compositions | |
IL259867B (en) | Polyelectrolyte-layer forming block copolymers and compositions and uses thereof | |
ZA201803451B (en) | Probiotic compositions and uses thereof | |
ZA201803875B (en) | Interleukin-15 compositions and uses thereof | |
SG11201707876YA (en) | Microalgal compositions and uses thereof | |
GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
SG11201605762QA (en) | Block copolymer composition and adhesive composition | |
SG11201605714VA (en) | Block copolymer and adhesive composition | |
GB201500692D0 (en) | Curable compositions and membranes | |
IL259202A (en) | Modified immune cells and uses thereof | |
GB201502002D0 (en) | Uses and compositions | |
EP3316871A4 (en) | Talc-bound compositions and uses thereof | |
IL254241A0 (en) | Etv2 and uses thereof | |
SG10202112759SA (en) | Antimalarial compositions and uses thereof | |
HK1250915A1 (en) | Composition and uses thereof | |
GB201501991D0 (en) | Uses and compositions | |
GB201502026D0 (en) | Uses and compositions | |
PL3387139T3 (en) | Beta-glucosidase and uses thereof | |
GB201512996D0 (en) | Compositions and methods |